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Abstract Minimally invasive esophagectomy (MIE) by
thoracoscopy after neoadjuvant therapy results in signifi-
cant short-term advantages such as a lower incidence of
pulmonary infections and a better quality of life (QoL) with
the same completeness of resection. After 1 year, a better
QoL is still observed for MIE in comparison with the open
approach, while having the same survival. Seven issues
about implementation of MIE for cancer require discus-
sion: (1) choice of the extension of esophageal resection
and use of neoadjuvant therapy; (2) reasons to approach the
esophageal cancer by MIE; (3) determining the best min-
imally invasive approach for gastro-esophageal junction
cancers; (4) implementation of evidence-based MIE; (5)
standardization of the surgical anatomy of the esophagus
based on MIE; (6) future lines of research of MIE; and (7)
learning process. In the time of imaging-integrated surgery
it is clear that the MIE approach should be increasingly
implemented in all centers worldwide having an adequate
volume of patients and expertise.
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Introduction
In 1991, Dallemagne introduced the right thoracoscopic
approach in lateral position for esophageal cancer with
total lung block, thereby mimicking the conventional
approach [1]. Initial reports showed a high conversion rate
to thoracotomy and a high respiratory morbidity. Searching
for reduction of the conversion rate and the respiratory
infection rate, Cuschieri et al. designed the thoracoscopic
approach in prone decubitus position so that a total collapse
of the lung was no longer necessary for dissecting the
esophagus and thereby possibly reducing the rate of res-
piratory infections [2].
After a feasibility period, the minimally invasive
esophagectomy (MIE) approach by thoracoscopy in prone
or lateral position or by transhiatal approach is being
widely implemented and increasingly performed all over
the world for patients with resectable esophageal cancer
(EC) to reduce postoperative respiratory complications and
to enhance the quality of life by avoiding a right thoraco-
tomy and laparotomy [3–5]. Other important, recent
developments in esophageal surgery concern the system-
atic use of neoadjuvant treatment, such as the use of
chemotherapy (MAGIC trial scheme) or chemoradiother-
apy (CROSS scheme) [6, 7]. Neoadjuvant therapy for
stages 2 and 3 significantly increases 5-year survival of
patients with esophageal cancer in both squamous cell
cancer (SCC) as well as adenocarcinomas (Adc).
Currently in discussion in the West is the extension of
mediastinal lymphadenectomy. Before, in 1994, the ISDE
had defined four types of mediastinal lymphadenectomy in
treating esophageal cancer (SCC) according to its exten-
sion: the standard, the extended, the total mediastinal and
the three-field [8]. The advent of imaging-integrated sur-
gery requires a new look at mediastinal lymphadenectomy.
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Statement about minimally invasive
esophagectomy (MIE)
The minimally invasive esophagectomy should entail the
same operation as the standard open esophageal resection
with the only difference being the approach: thoracoscopy
instead of thoracotomy and laparoscopy instead of
laparotomy.
Seven issues will be discussed about the implementation
of MIE for cancer:
1. Choice of the extension of esophageal resection, and
use of neoadjuvant therapy.
2. Reasons to approach the esophageal cancer by MIE.
3. Determining the best minimally invasive approach for
gastro-esophageal junction (GEJ) cancers.
4. Implementation of evidence based MIE.
5. Standardization of the surgical anatomy of the esoph-
agus based on MIE.
6. Future lines of research of MIE.
7. Learning process.
The choice of the extension for MIE esophageal
resection and use of neoadjuvant therapy
Based on information gathered in Japan about the fre-
quency of lymph node metastases according to tumor
location [9] and the evidence obtained by randomized
controlled trials (RCT) such as the HIVEX trial [10],
middle and upper esophageal cancers may be approached
by a three-stage thoracoscopy with total mediastinal lym-
phadenectomy (LN) and laparoscopy with cervical anas-
tomosis after neoadjuvant therapy. In cases of lower
esophageal and GEJ, Siewert 1 and 2, a three-stage or a
two-stage Ivor Lewis operation is performed, by laparo-
scopy and thoracoscopy with standard LN with intratho-
racic anastomosis after neoadjuvant therapy [11]. If there is
a suspicion of enlarged lymph nodes by PET CT-scan in
the paratracheal area in these distal tumors, mostly Adc,
LN of these areas is also added. In high-risk patients with
distal or GEJ cancers, the laparoscopic transhiatal approach
is an option after neoadjuvant therapy.
Reasons to approach the esophageal cancer
by MIE
There is less operative trauma and consequently less
morbidity. Performing a thoracoscopy avoids a thoraco-
tomy. Possibly there are fewer postoperative pulmonary
complications, especially if no complete pulmonary block
had to be used, as done in thoracoscopy in prone position.
In laparoscopic transhiatal dissection, the operation is
performed under direct vision and probably with less
manipulation and retraction of the mediastinum (heart) and
therefore less hemodynamic complications. It will add to a
better quality of life and perhaps a better survival [12–17].
All surgical approaches used for open esophagectomy
have been implemented for MIE. The transhiatal approach,
the three-stage esophageal resection, the Ivor Lewis oper-
ation, the thoracoscopy in prone position and the esopha-
geal resection facilitated by robot [1–5, 18–21].
Determining the best minimally invasive approach
for gastro-esophageal junction (GEJ) cancers
Gastroesophageal junction adenocarcinomas account for
30–40 % of all esophageal cancers in the West. We use—
accepting its limitations—the Siewert classification to
locate these tumors leading to implications for the type of
neoadjuvant therapy but also for the surgical approach.
Many oncologists will indicate neoadjuvant chemotherapy
for these tumors. Type 1 is located mainly on the side of
the esophagus, type 3 on the side of the gastric cardias and
type 2 between both. For type 3 we performed a laparo-
scopic total gastrectomy [11]. For type 2, an MIE Ivor
Lewis procedure is the main choice or the laparoscopic
total gastrectomy with an esophagogastrostomy using the
Orvil or a linear stapler anastomosis through the tran-
shiatal approach. Some surgeons will indicate a laparo-
scopic transhiatal esophageal resection with gastric conduit
anastomosis in cervical area and in the case of extensive
growth of the tumor along the lesser curvature an open
esophageal and gastric resection followed by a colon
interposition. Finally for the type 1 tumor, a laparoscopic 2
stage Ivor Lewis or a 3-stage MacKeown approach will be
the choice.
The Ivor Lewis approach with intrathoracic anastomosis
is a perfect operation for many infracarinal esophageal
cancers [22, 23]. Whilst textbook, it is an operation with a
high difficulty grade because of the intrathoracic anasto-
mosis. The operation commences with laparoscopy (celiac
trunk lymphadenectomy, gastric dissection, creation of a
gastric conduit and hiatal dissection) followed by right
thoracoscopy (esophageal resection and lymphadenec-
tomy) and intrathoracic anastomosis through thoracoscopy.
While there are different types of intrathoracic anastomo-
sis, nonetheless no evidence posits one as graded superior
to the other.
In overview, we have the manual anastomosis or an end-
to-side anastomosis with a conventional circular stapler
(21, 25 or 28 mm after a pursestring suture on the eso-
phageal stump or a prepared Orvil device). Furthermore,
the side-to-side anastomosis can be performed using a
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linear stapler, closing the anterior defect by a transversal
suture using conventional suture material or the prepared
V-Lock [24]. Finally the robot-assisted anastomosis is
increasingly used permitting a manual high anastomosis in
the apex of the thorax because of the ergonomy obtained by
the robot [25].
In the Netherlands, anastomotic leaks after MIE Ivor
Lewis had initially been reported as high as 14 %, subse-
quently reduced to current rates holding between 5 and
10 % with a low mortality of 2.1 %. Surgeons must adhere
to a proper algorithm for treating these postoperative
anastomotic leaks as early as possible, thereby following
the maxim that: ‘‘Patients who do not progress every day
should be studied immediately by CT-scan and endoscopy
for assessment of the anastomosis’’.
Implementation of evidence based MIE
There is noteworthy implementation of MIE all over the
world. In 2015, using the PubMed we located 748 papers
on MIE esophagectomy and 478 for specifically thoraco-
scopic esophagectomy. There are four meta-analyses and
one randomized controlled trial, being the TIME trial,
which compared the total MIE by thoracoscopy in prone
and laparoscopy versus the total open approach [12, 26–
30]. The French MIRO hybrid trial comparing laparoscopy
and thoracotomy with intrathoracic anastomosis versus
open approach has already been presented at congresses
but has not yet been published [31].
The three most important large series are: the Hulscher’s
series with open transthoracic approach in lateral decubitus
(114 patients), the Luketich’s series published in 2003 with
patients operated by thoracoscopy in lateral position (222
patients), and the Palanivelu’s series of 130 patients
operated in thoracoscopic prone position. Comparing these,
we see an overall survival rate at 3 years of 40, 34 and
42 %, respectively. Moreover, the comparative rates of
pulmonary complications were 57, 20 and 2.3 %, respec-
tively; while the comparative rates of median Intensive
Care stay were 6 days, 1 day and 1 day, respectively; and a
hospital stay of 19, 7 and 8 days, respectively [3, 4, 10].
These striking differences called for evidence-based
analysis of effectiveness. Therefore, from 2010 to 2012 the
TIME trial was performed in our department. This was a
multicentre, open-label randomized controlled trial [30]
comparing thoracoscopy in prone position plus laparoscopy
versus right posterolateral thoracotomy and laparotomy
followed by intrathoracic or cervical anastomosis after
neoadjuvant therapy. Primary end point of the trial was
determining the rates of respiratory infections in the first
2 weeks and in-hospital stay, while the secondary end
points were the quality of the specimen and quality of life
(QoL).We analyzed hospital stay, operative data, postop-
erative data, complication rate, mortality rates and survival
rates.
Concerning the primary outcome, a statistical difference
in incidence of postoperative pulmonary infections at end
of 2 weeks compared to in-hospital stay was 9 versus 29 %
and 12 versus 34 %, respectively, in favor of the MIE
group. Concerning the secondary outcomes, hospital stay
was statistically different (11 and 14 days) in favor of the
MIE; but also different answers in the QoL questionnaires
(the SF-36 physical component), EORTC C30 (global
health) and OES 18 (taking and pain) were found at
2 weeks after operation in favor of MIE. Moreover other
outcomes such as the total of retrieved lymph nodes, the
rate of R0 resection (98 and 90 %), and the in-hospital
mortality rates (3.4 and 1.8 %) were not statistically dif-
ferent between the two groups. Other outcomes, such as
operative time, were shorter in the open group whereas
blood loss and the VAS score were less in MIE group.
Importantly, the outcomes of technical complications such
as anastomotic leakage and thoracic complications were
not different between the groups, whilst the only exception
being incidence of vocal cord palsy that showed an initial
difference of 2 versus 14 % in favor of the MIE group.
Explanation for this outcome is difficult but has to be
sought in the leakage of CO2 from the thorax in the cervical
area needed to create a better plane for dissection. The rates
of reoperations (14 and 10 %, respectively) were no dif-
ferent between the two groups. Moreover, at 1-year follow
up there were no differences in overall and disease-free
survival rates between the two groups (around 75 %) yet
the QoL questionnaires point out some differences at the
1-year juncture. The global health, the pain and the phys-
ical component of the SF-36 were still statistically different
after 1 year in favor of the MIE intervention. Explanation
for this is obtained by the advantage of avoidance of the
thoracotomy with prevention of the postthoracotomy syn-
drome [32].
Furthermore, there are four different MIE approaches:
(a) the lateral thoracoscopic position, the prone position
and the semiprone position [1, 2, 33]; (b) the Hybrid MIE
type 1 in which a laparoscopy is combined with a right
thoracotomy as in the French MIRO trial [31], (c) the
Hybrid MIE 2 that combines a thoracoscopy and the
laparotomy [13], and (d) the robot-assisted thoracoscopy
with standard laparoscopy [21].
Concerning the semiprone position as proposed in
Japan, this seems an important addition to the standard
prone approach. This includes the possibility to balance the
patient from prone to right semi lateral in order to better
visualize the supracarinal area and do a better lym-
phadenectomy along both recurrent laryngeal nerves [33].
Concerning the thoracoscopy in prone approach there are
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some differences in the position of trocars between Japa-
nese and western world surgeons. The first positions the
trocars anteriorly of the scapula adding mostly a small
thoracotomy for retraction, whereas the second positions
the trocars posteriorly, between the scapula and the spine,
adding only a small thoracotomy at the end of the proce-
dure for retrieval of the specimen and introduction of the
circular stapler in the case of Ivor Lewis operation.
Differences between the lateral and prone position show
that, while in the prone position there is no necessity for
selective intubation in the case of cervical anastomosis (we
use an insufflation of 7–8 mm Hg CO2 for helping retrac-
tion of the lung) in the lateral position selective intubation
is usually used. When questions arise whether a quick
conversion to thoracotomy is needed because of bleeding,
sufficient experience assures that conversion may be per-
formed in both positions.
Differences between prone and lateral position are
studied by Kubo et al. with two cohorts of 28 patients in
lateral and 30 in prone position. Blood loss and duration of
systemic inflammatory response were significantly better in
the prone group, with a tendency of the respiratory com-
plications to be also lower in the prone group. Their con-
clusion was that while thoracoscopy in lateral position was
safe and feasible, the prone position might be a potentially
less invasive procedure than the lateral position [34].
The FREGAT French group compared the 30-day
postoperative mortality (POM) between two important
cohorts of patients (663 MIE and 2346 open esophagec-
tomy patients) of the French register. Thirty-day postop-
erative mortality was 3.3 versus 5.7 %, the in-hospital
mortality 5.6 versus 8.1 % and at 90-day mortality 6.9 and
10 %, respectively; where the 30-day POM was signifi-
cantly favoring the MIE. This study suggests that POM is
significantly reduced after MIE for EC. This is highly
valuable evidence for aiding in decision-making regarding
an optimal (hybrid 1 MIE) approach [35].
Concerning long-term survival, Burdall et al. reported
three large series in the UK: the open approach (83
patients), the MIE (64 patients) and the hybrid type 1 (187
patients). They found in the long term that the probability
of the length of survival for the three groups, even with no
adjustment for T or N stage, was greatest for the MIE group
[36].
Standardization of the surgical anatomy
of the esophagus based on MIE
The information gathered by MIE has permitted us to
describe the concept of the meso-esophagus in the sub-
carinal area of the thoracic esophagus. During thora-
coscopy in prone position we have observed that all
structures at subcarinal level, vessels, lymph vessels and
nerves are coming from the side of the thoracic aorta to the
esophagus. There is a double fascia between aorta and the
esophagus that has to be divided in order to perform a
systematic step-by-step MIE. In the supracarinal esophagus
it is different because the vessels, nerves and lymph vessels
are coming on both sides of the esophagus. Description of
which structures have to be divided and which to be pre-
served at this level is important for an adequate esophageal
resection and lymphadenectomy with preservation of the
arterial vascularization of the trachea and bronchi and
proper innervation to the lungs [37, 38].
Future lines of research of MIE
There are some ongoing RCT’s such as the ROBOT trial
that compares the open esophagectomy with the thoraco-
scopic approach assisted by the robot [21], but also RCT’s
that will compare the MIE with the open and hybrid
approaches. In the UK and in Japan surgeons still harbor
doubts about the advantages of MIE, therefore three new
trials have been started. In the UK, the ROMIO trial with
three arms: the MIE, the hybrid 1 and the open [39]. In
Japan surgeons are comparing the prone position with the
open esophagectomy and in China they are going to initiate
a RCT comparing the lateral MIE with the open approach
[40].
Learning process
To initiate teaching of the MIE approach, surgeons of a
designated proctored Upper GI group will need to have
access to an adequate volume of patients with EC and have
gained enough experience in open esophagectomy and
minimally invasive surgery. Moreover, with the approval
of the direction of the hospital and the department they
have to organize a dedicated team (at least with 2 surgeons)
and visit a center of excellence to learn how this type of
intervention has to be performed. Consequently, apprentice
learners, will under the guidance of an authorized mentor
need to be monitored while carrying out several MIE
procedures in their own hospital.
Conclusion
Minimally invasive esophagectomy after neoadjuvant
therapy results in significant advantages on the short term
such as lower incidence of pulmonary infections and a
better short-term QoL with the same completeness of
resection. After 1 year there is still a better QoL with the
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same survival rate. Three more RCT’s are planned to fol-
low up on the established practice of video-assisted tho-
racoscopic esophagectomy; together with the publication
of the French MIRO hybrid trial, we may expect significant
improvements in reducing morbidity and increasing the
benefits of the intrathoracic anastomosis.
In the time of imaging-integrated surgery it is clear that
the MIE approach should be increasingly implemented in
all centers worldwide having an adequate volume of
patients and expertise.
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